Concentration: Biomedical Devices

close up photo of the CellScope

Biomedical Devices focuses on the development of new biomedical technology for life science research and advanced health care. This concentration provides training in fundamental aspects of cell biology and physiology in addition to traditional areas of mechanical and electrical engineering as applied to biotechnology and medical devices.

Real-World Applications

Diagnostics, sensing and monitoring, remote healthcare, lab-on-a-chip, drug delivery systems, brain-machine interface, microfluidics.

News About: Biomedical Devices

Aris and Lowet receive Jane Coffin Childs Fellowships

Congratulations to two postdoctoral scholars in BioE lab who have been named 2026 Jane Coffin Childs Fellows! The charitable fund supports brilliant postdoctoral fellows conducting fundamental research on cancer and human disease. Kevin Aris, PhD, works in Aaron Streets’ lab on tools to measure DNA supercoiling in living cells, to build a genome-wide map of DNA shape. Adam Lowet, PhD. works with Michael Yartsev to explore the computational and biological mechanisms underlying social decision-making in the Egyptian fruit bat.

Herr Lab and partners receive grant to study biology in time and space

Our researchers have received a new grant from the Biohub non-profit research organization, looking to advance the field of Spatiotemporal omics – the ability to sample biomolecules at different locations and times to watch disease processes unfold. Amy Herr and her UCSF partners Jennifer Rosenbluth and Amrita Basu will be studying integrated organoid systems for immunotherapy toxicity.

Herr wins Weill Neurohub Investigator Award

A research project on “the protein code of brain aging: from molecules to mechanisms,” by Professor Amy Herr has been selected for a Weill Neurohub Investigator Award. The Investigators program funds top faculty to form cross-campus, interdisciplinary teams to explore, create, and test bold new concepts and technologies.

Heart-on-a-chip may lead to new treatments for heart failure

A team led by Professors Kevin Healy and Niren Murthy have developed a microfluidic heart-on-a-chip, with which they were able to discover a lipid nanoparticle that could penetrate the dense heart muscle and efficiently deliver its cargo of therapeutic mRNA into heart muscle cells. This new drug delivery method and testing platform may pave the way to new cardiac treatments.

Fletcher elected to National Academy of Medicine

Professor Dan Fletcher has been elected to the National Academy of Medicine for his contributions to the mechanistic understanding of biological self-assembly and mechanotransduction, and his work developing mobile phone-based microscopy for remote diagnosis of infectious diseases. Election to the academy is considered one of the highest honors in the fields of health and medicine.

Aaron Streets named AIMBE Fellow

Professor Aaron Streets has been named to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE). Streets was selected for “developing innovative technology to elucidate genome regulation with single-cell and molecule resolution, and for impactful leadership to diversify bioengineering.

BlotSeq single cell sequencing – animated!

BioE postdoc Trinh Lam’s animated video explains how Herr Lab’s BlotSeq single-cell tool uses sequencing data to guide protein selection without the need to predefine targets, making the process more flexible.

Diverse paths to discovery at UC Berkeley

BioE graduate student Jazmin Isabel Velazquez examines the unique paths every graduate student takes on the road to their PhD in this story based on her experience in the Healy and Rubinsky Labs.

Herr Lab Postdoc Wins AIP Best Paper

Trinh Lam, a postdoc in Amy Herr’s lab, has won the Biomicrofluidics Best Paper Award from AIP Publishing at the 28th International Conference on Miniaturized Systems for Chemistry and Life Sciences – Micro-Total Analysis Systems (µTAS 2024).

Yartsev new HHMI Investigator

Congratulations Professor Michael Yartsev, named a Howard Hughes Medical Institute (HHMI) Investigator!